Circassia Holdings Ltd

Bachem is specializes in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research.

For more information please visit www.bachem.com.

Pharm-Olam International is a multi-national contract research organisation offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries.

For more information please visit www.pharm-olam.com.

Cetero Research is an industry leading CRO in clinical pharmacology, bioanalytical, and specialty Phase II-IV services.

For more information please visit www.cetero.com.

Nova Laboratories is a UK and international pharmaceutical aseptic contract manufacturing company, and is a key member of Circassia's out-sourced pharmaceutical development team.

For more information please visit www.novalabs.co.uk.

Tepnel Life Sciences is a UK-based international life sciences products and services group with two divisions, Molecular Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France.

For more information please visit www.tepnel.com.

Excella is a well established active pharmaceutical ingredient manufacturer based in Germany. The company is a key part of Circassia’s outsourced production team.

Circassia's lead investor is Imperial Innovations the technology transfer and commercialisation company based at Imperial College London.

Please visit www.imperialinnovations.co.uk for more information.

PriceWaterhouseCoopers are the Company's auditors.